Drug Type Fecal microbiota transplantation |
Synonyms- |
Target- |
Mechanism Bacteria replacements, Microbiome modulators |
Active Indication |
Inactive Indication |
Originator Organization ProgenaBiome LLCStartup |
Active Organization ProgenaBiome LLCStartup |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Parkinson Disease | Phase 1 | US | ProgenaBiome LLCStartup | 16 Oct 2024 |
Autism Spectrum Disorder | Phase 1 | US | ProgenaBiome LLCStartup | 01 May 2022 |
Autistic Disorder | Phase 1 | US | ProgenaBiome LLCStartup | 01 May 2022 |
Language Disorders | Phase 1 | US | ProgenaBiome LLCStartup | 01 May 2022 |
Mesothelioma | Phase 1 | US | ProgenaBiome LLCStartup | 18 Sep 2018 |